Cargando…

Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty

AIM: “Consensual ophthalmotonic reaction” refers to changes in intraocular pressure (IOP) in one eye, which is accompanied by a corresponding change in IOP in the contralateral eye. This study evaluates whether monocular administration of selective laser trabeculoplasty (SLT) leads to a consensual o...

Descripción completa

Detalles Bibliográficos
Autores principales: Nassiri, Nariman, Mei, Frank, Tokko, Hassan, Zeiter, John, Syeda, Sarah, Kim, Chaesik, Swendris, Ronald, Goyal, Anju, Veld, Elise In'T, Mas-Ramirez, Alma, Rana, Sonia W, Juzych, Mark S, Hughes, Bret A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385382/
https://www.ncbi.nlm.nih.gov/pubmed/36060042
http://dx.doi.org/10.5005/jp-journals-10078-1361
_version_ 1784769580408766464
author Nassiri, Nariman
Mei, Frank
Tokko, Hassan
Zeiter, John
Syeda, Sarah
Kim, Chaesik
Swendris, Ronald
Goyal, Anju
Veld, Elise In'T
Mas-Ramirez, Alma
Rana, Sonia W
Juzych, Mark S
Hughes, Bret A
author_facet Nassiri, Nariman
Mei, Frank
Tokko, Hassan
Zeiter, John
Syeda, Sarah
Kim, Chaesik
Swendris, Ronald
Goyal, Anju
Veld, Elise In'T
Mas-Ramirez, Alma
Rana, Sonia W
Juzych, Mark S
Hughes, Bret A
author_sort Nassiri, Nariman
collection PubMed
description AIM: “Consensual ophthalmotonic reaction” refers to changes in intraocular pressure (IOP) in one eye, which is accompanied by a corresponding change in IOP in the contralateral eye. This study evaluates whether monocular administration of selective laser trabeculoplasty (SLT) leads to a consensual ophthalmotonic reaction and how long this effect lasts. MATERIALS AND METHODS: A retrospective chart review was performed on patients receiving SLT at Kresge Eye Institute in Detroit, MI, from January 2015 to August 2016. Patients were excluded if they had previous history of glaucoma incisional and/or laser procedures; required additional laser trabeculoplasty; had glaucoma medication changes during the follow-up period; experienced no decrease in IOP during the follow-up period; or had a diagnosis of angle closure on gonioscopy. Various demographic, clinical, and surgical data were collected. IOP measurements were collected at baseline and postoperatively at 1–3 months, 4–9 months, and 12–15 months. RESULTS: At all follow-up periods, the IOP of the treated eye was decreased from baseline IOP (p ≤ 0.05, paired t-test). For the fellow eye, there was a statistically significantly decrease from baseline up to the 4–9 months follow-up period (p ≤ 0.05, paired t-test). Linear regression analysis of the percent reduction in IOP from baseline in the SLT-treated eye with the fellow eye shows a mild correlation at all-time points: R(2) = 0.284 (p < 0.001) at 1–3 months; R(2) = 0.348 (p < 0.001) at 4–9 months; R(2) = 0.118 (p = 0.054) at 12–15 months. CONCLUSION: This study showed that monocular administration of SLT results in a consensual ophthalmotonic reaction. The consensual ophthalmotonic reaction appears to last for up to 4–9 months. CLINICAL SIGNIFICANCE: Therefore, although SLT does lead to a consensual ophthalmotonic reaction, monocular administration of SLT is not a reliable method of long-term IOP control for the contralateral non-SLT-treated eye. HOW TO CITE THIS ARTICLE: Nassiri N, Mei F, Tokko H, et al. Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty. J Curr Glaucoma Pract 2022;16(1):36–40.
format Online
Article
Text
id pubmed-9385382
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-93853822022-09-02 Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty Nassiri, Nariman Mei, Frank Tokko, Hassan Zeiter, John Syeda, Sarah Kim, Chaesik Swendris, Ronald Goyal, Anju Veld, Elise In'T Mas-Ramirez, Alma Rana, Sonia W Juzych, Mark S Hughes, Bret A J Curr Glaucoma Pract Original Research AIM: “Consensual ophthalmotonic reaction” refers to changes in intraocular pressure (IOP) in one eye, which is accompanied by a corresponding change in IOP in the contralateral eye. This study evaluates whether monocular administration of selective laser trabeculoplasty (SLT) leads to a consensual ophthalmotonic reaction and how long this effect lasts. MATERIALS AND METHODS: A retrospective chart review was performed on patients receiving SLT at Kresge Eye Institute in Detroit, MI, from January 2015 to August 2016. Patients were excluded if they had previous history of glaucoma incisional and/or laser procedures; required additional laser trabeculoplasty; had glaucoma medication changes during the follow-up period; experienced no decrease in IOP during the follow-up period; or had a diagnosis of angle closure on gonioscopy. Various demographic, clinical, and surgical data were collected. IOP measurements were collected at baseline and postoperatively at 1–3 months, 4–9 months, and 12–15 months. RESULTS: At all follow-up periods, the IOP of the treated eye was decreased from baseline IOP (p ≤ 0.05, paired t-test). For the fellow eye, there was a statistically significantly decrease from baseline up to the 4–9 months follow-up period (p ≤ 0.05, paired t-test). Linear regression analysis of the percent reduction in IOP from baseline in the SLT-treated eye with the fellow eye shows a mild correlation at all-time points: R(2) = 0.284 (p < 0.001) at 1–3 months; R(2) = 0.348 (p < 0.001) at 4–9 months; R(2) = 0.118 (p = 0.054) at 12–15 months. CONCLUSION: This study showed that monocular administration of SLT results in a consensual ophthalmotonic reaction. The consensual ophthalmotonic reaction appears to last for up to 4–9 months. CLINICAL SIGNIFICANCE: Therefore, although SLT does lead to a consensual ophthalmotonic reaction, monocular administration of SLT is not a reliable method of long-term IOP control for the contralateral non-SLT-treated eye. HOW TO CITE THIS ARTICLE: Nassiri N, Mei F, Tokko H, et al. Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty. J Curr Glaucoma Pract 2022;16(1):36–40. Jaypee Brothers Medical Publishers 2022 /pmc/articles/PMC9385382/ /pubmed/36060042 http://dx.doi.org/10.5005/jp-journals-10078-1361 Text en Copyright © 2022; The Author(s). https://creativecommons.org/licenses/by-nc/4.0/© The Author(s). 2022 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Research
Nassiri, Nariman
Mei, Frank
Tokko, Hassan
Zeiter, John
Syeda, Sarah
Kim, Chaesik
Swendris, Ronald
Goyal, Anju
Veld, Elise In'T
Mas-Ramirez, Alma
Rana, Sonia W
Juzych, Mark S
Hughes, Bret A
Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty
title Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty
title_full Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty
title_fullStr Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty
title_full_unstemmed Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty
title_short Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty
title_sort consensual ophthalmotonic reaction following selective laser trabeculoplasty
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385382/
https://www.ncbi.nlm.nih.gov/pubmed/36060042
http://dx.doi.org/10.5005/jp-journals-10078-1361
work_keys_str_mv AT nassirinariman consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty
AT meifrank consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty
AT tokkohassan consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty
AT zeiterjohn consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty
AT syedasarah consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty
AT kimchaesik consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty
AT swendrisronald consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty
AT goyalanju consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty
AT veldeliseint consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty
AT masramirezalma consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty
AT ranasoniaw consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty
AT juzychmarks consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty
AT hughesbreta consensualophthalmotonicreactionfollowingselectivelasertrabeculoplasty